Larimar Therapeutics (LRMR) Non Operating Income (2016 - 2020)
Historic Non Operating Income for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to $218000.0.
- Larimar Therapeutics' Non Operating Income rose 3212.12% to $218000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $301000.0, marking a year-over-year increase of 7398.84%. This contributed to the annual value of $248000.0 for FY2019, which is 20081.3% up from last year.
- As of Q1 2020, Larimar Therapeutics' Non Operating Income stood at $218000.0, which was up 3212.12% from $30000.0 recorded in Q4 2019.
- In the past 5 years, Larimar Therapeutics' Non Operating Income registered a high of $273000.0 during Q4 2017, and its lowest value of -$254000.0 during Q1 2018.
- Its 5-year average for Non Operating Income is $90470.6, with a median of $121000.0 in 2016.
- Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 65833.33% in 2017, then crashed by 21375.66% in 2018.
- Over the past 5 years, Larimar Therapeutics' Non Operating Income (Quarter) stood at $36000.0 in 2016, then surged by 658.33% to $273000.0 in 2017, then crashed by 55.68% to $121000.0 in 2018, then plummeted by 75.21% to $30000.0 in 2019, then skyrocketed by 626.67% to $218000.0 in 2020.
- Its last three reported values are $218000.0 in Q1 2020, $30000.0 for Q4 2019, and -$8000.0 during Q3 2019.